$CSBR
Champions Oncology, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Champions Oncology, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CSBR down today? It is at $4.34 (-1.36%). See the catalyst behind the move, real-time alerts the moment CSBR spikes, and full due diligence on CSBR — key stats, earnings, dilution and insider activity. Free.
Be first to know when $CSBR makes an unusual move. Create a free account to track $CSBR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how CSBR traded in the last session, Friday (last price and move above). Our scanner did not detect an unusual-volume catalyst for CSBR on Friday, so it traded in line with its recent range. When trading resumes, the moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 9, 2026 · 12 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ackerman Joel Director | Other | 70K 0.5% of company | added 6.6% | 1.13M | $112K at $1.60 | Oct 15, 26 |
Ackerman Joel Director | Other | 94K 0.7% of company | added 9.8% | 1.06M | $198K at $2.10 | Oct 30, 25 |
Breitfeld Philip P. Director | Sold (automatic/other) | -4K 0.03% of company | sold 42% | 6K | n/a | Mar 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.




The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
The market is closed. Here is how CSBR traded in the last session, Friday (last price and move above). Our scanner did not detect an unusual-volume catalyst for CSBR on Friday, so it traded in line with its recent range. When trading resumes, the moment our scanner flags unusual activity, the reason will appear here.
CSBR last traded at $4.34, down 1.36% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Champions Oncology, Inc. (CSBR) is next expected to report earnings on Monday, December 21, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CSBR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire.
CSBR (Champions Oncology, Inc.) trades on XNAS, with a market cap of about $60M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CSBR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CSBR discussion
Sign in to ask a question or join the discussion.